286 related articles for article (PubMed ID: 24684280)
1. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
Huso TH; Resar LM
Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin.
Sharma A; Ray R; Rajeswari MR
Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384
[TBL] [Abstract][Full Text] [Related]
4. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
5. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
7. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
8. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
9. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
10. Regulation of microRNA expression by HMGA1 proteins.
De Martino I; Visone R; Fedele M; Petrocca F; Palmieri D; Martinez Hoyos J; Forzati F; Croce CM; Fusco A
Oncogene; 2009 Mar; 28(11):1432-42. PubMed ID: 19169275
[TBL] [Abstract][Full Text] [Related]
11. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
12. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of HMGA1 expression by short/small hairpin RNA inhibits growth of ovarian carcinoma cells.
Liu Y; Wang Y; Zhang Y; Fu J; Zhang G
Biotechnol Appl Biochem; 2012; 59(1):1-5. PubMed ID: 22332738
[TBL] [Abstract][Full Text] [Related]
15. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
16. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R
Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961
[TBL] [Abstract][Full Text] [Related]
17. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
[TBL] [Abstract][Full Text] [Related]
18. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
Resar L; Chia L; Xian L
Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
[TBL] [Abstract][Full Text] [Related]
19. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
20. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]